Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Ovarian Epithelial × Letrozole × Clear all

Phase

Status

Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 39 Neoplasm Metastasis 5 Neoplasms, Hormone-Dependent 2 Carcinoma, Lobular 2 Carcinoma, Ductal, Breast 2 Advanced Breast Cancer 2 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Medullary cystic kidney disease 1 1 Lymphoma, Non-Hodgkin 1 Leiomyosarcoma 1 Hormone-sensitive Metastatic Breast Cancer 1 HER2-positive Breast Cancer 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Cancer Metastatic 1

Interventions

Paclitaxel 18 Carboplatin 13 Topotecan 7 liposomal doxorubicin 6 Cyclophosphamide 5 Cisplatin 5 Docetaxel 4 Gemcitabine 3 Etoposide 3 Capecitabine 3 pembrolizumab 2 oregovomab 2 fludarabine phosphate 2 aldesleukin 2 Taxes 2 Surgical Procedures, Operative 2 Stem Cell Transplantation 2 STA 9090 2 Peripheral Blood Stem Cell Transplantation 2 Oxaliplatin 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Immunoenzyme Techniques 2 Fluorodeoxyglucose F18 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 Amplified Fragment Length Polymorphism Analysis 2 1-dodecylpyridoxal 2 volociximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04421547 2025-03-07

MITO32

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Terminated

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡